Literature DB >> 24518819

Nitric oxide and hypoxia stimulate erythropoietin receptor via MAPK kinase in endothelial cells.

Bojana B Beleslin Cokic1, Vladan P Cokic2, Sukanya Suresh3, Stacey Wirt3, Constance Tom Noguchi3.   

Abstract

Erythropoietin receptor (EPOR) expression level determines the extent of erythropoietin (EPO) response. Previously we showed that EPOR expression in endothelial cells is increased at low oxygen tension and that EPO stimulation of endothelial cells during hypoxia can increase endothelial nitric oxide (NO) synthase (eNOS) expression and activation as well as NO production. We now observe that while EPO can stimulate NO production, NO in turn can regulate EPOR expression. Human umbilical vein endothelial cells (HUVEC) treated with 10-50 μM of NO donor diethylenetriamine NONOate (DETANO) for 24h showed significant induction of EPOR gene expression at 5% and 2% of oxygen. Also human bone marrow microvascular endothelial cell line (TrHBMEC) cultured at 21 and 2% oxygen with 50 μM DETANO demonstrated a time and oxygen dependent induction of EPOR mRNA expression after 24 and 48 h, particularly at low oxygen tension. EPOR protein was also induced by DETANO at 2% oxygen in TrHBMEC and HUVEC. The activation of signaling pathways by NO donor stimulation appeared to be distinct from EPO stimulation. In reporter gene assays, DETANO treatment of HeLa cells at 2% oxygen increased EPOR promoter activity indicated by a 48% increase in luciferase activity with a 2 kb EPOR promoter fragment and a 71% increase in activity with a minimal EPOR promoter fragment containing 0.2 kb 5'. We found that DETANO activated MAPK kinase in TrHBMEC both in normoxia and hypoxia, while MAPK kinase inhibition showed significant reduction of EPOR mRNA gene expression at low oxygen tension, suggesting MAPK involvement in NO mediated induction of EPOR. Furthermore, DETANO stimulated Akt anti-apoptotic activity after 30 min in normoxia, whereas it inhibited Akt phosphorylation in hypoxia. In contrast, EPO did not significantly increase MAPK activity while EPO stimulated Akt phosphorylation in TrHBMEC in normoxia and hypoxia. These observations provide a new effect of NO on EPOR expression to enhance EPO response in endothelial cells, particularly at low oxygen tensions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24518819      PMCID: PMC3982609          DOI: 10.1016/j.mvr.2014.01.009

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  28 in total

1.  Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin.

Authors:  Livius V d'Uscio; Leslie A Smith; Anantha V Santhanam; Darcy Richardson; Karl A Nath; Zvonimir S Katusic
Journal:  Hypertension       Date:  2007-03-19       Impact factor: 10.190

2.  Nitric oxide inhibits gastric cancer cell growth through the modulation of the Akt pathway.

Authors:  Jianrong Sang; Yongchang Chen; Yan Tao
Journal:  Mol Med Rep       Date:  2011-07-15       Impact factor: 2.952

3.  In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries.

Authors:  Anantha Vijay R Santhanam; Leslie A Smith; Karl A Nath; Zvonimir S Katusic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-03-24       Impact factor: 4.733

4.  Nitric oxide induces promyelocytic cell growth arrest and apoptosis through deactivation of Akt pathway.

Authors:  Xiaojian Wang; Hongying Sun; Chaolong Li
Journal:  Leuk Res       Date:  2006-09-06       Impact factor: 3.156

5.  AMP-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase.

Authors:  Kuo-Hui Su; Yuan-Bin Yu; Hsin-Han Hou; Jin-Feng Zhao; Yu Ru Kou; Li-Ching Cheng; Song-Kun Shyue; Tzong-Shyuan Lee
Journal:  J Cell Physiol       Date:  2012-08       Impact factor: 6.384

6.  Erythropoietin and hypoxia increase erythropoietin receptor and nitric oxide levels in lung microvascular endothelial cells.

Authors:  Bojana B Beleslin-Čokić; Vladan P Cokić; Li Wang; Barbora Piknova; Ruifeng Teng; Alan N Schechter; Constance T Noguchi
Journal:  Cytokine       Date:  2011-02-15       Impact factor: 3.861

Review 7.  Hypoxia inducible factor 1 (HIF-1) and cardioprotection.

Authors:  Demet Tekin; Ali D Dursun; Lei Xi
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

8.  Activation of Hsp90-eNOS and increased NO generation attenuate respiration of hypoxia-treated endothelial cells.

Authors:  Tennille Presley; Kaushik Vedam; Murugesan Velayutham; Jay L Zweier; Govindasamy Ilangovan
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-11       Impact factor: 4.249

Review 9.  Survival and proliferative roles of erythropoietin beyond the erythroid lineage.

Authors:  Constance Tom Noguchi; Li Wang; Heather M Rogers; Ruifeng Teng; Yi Jia
Journal:  Expert Rev Mol Med       Date:  2008-12-01       Impact factor: 5.600

10.  Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide.

Authors:  Shih-Chung Chen; Yu-Chi Liu; Kou-Gi Shyu; Danny Ling Wang
Journal:  Atherosclerosis       Date:  2008-03-10       Impact factor: 5.162

View more
  10 in total

1.  Effects of Danhong Injection (丹红注射液) and its main components on anticoagulation and fibrinolysis in cultured vein endothelial cells.

Authors:  Yu-yan Zhang; Hui-fen Zhou; Jie-hong Yang; Yu He; Xiao-qiang Chen; Katsuyoshi Nishinari; Hao-fang Wan; Hai-tong Wan
Journal:  Chin J Integr Med       Date:  2016-04-09       Impact factor: 1.978

2.  Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia.

Authors:  Miyuki Yokoro; Yosuke Nakayama; Sho-Ichi Yamagishi; Ryotaro Ando; Miki Sugiyama; Sakuya Ito; Junko Yano; Kensei Taguchi; Yusuke Kaida; Daisuke Saigusa; Masumi Kimoto; Takaaki Abe; Seiji Ueda; Kei Fukami
Journal:  J Am Soc Nephrol       Date:  2017-06-09       Impact factor: 10.121

3.  Low Oxygen Tension Primes Aortic Endothelial Cells to the Reparative Effect of Tissue-Protective Cytokines.

Authors:  Lamia Heikal; Pietro Ghezzi; Manuela Mengozzi; Gordon Ferns
Journal:  Mol Med       Date:  2015-09-01       Impact factor: 6.354

4.  Erythropoietin and a nonerythropoietic peptide analog promote aortic endothelial cell repair under hypoxic conditions: role of nitric oxide.

Authors:  Lamia Heikal; Pietro Ghezzi; Manuela Mengozzi; Blanka Stelmaszczuk; Martin Feelisch; Gordon Aa Ferns
Journal:  Hypoxia (Auckl)       Date:  2016-08-16

Review 5.  Ordinary and Activated Bone Grafts: Applied Classification and the Main Features.

Authors:  R V Deev; A Y Drobyshev; I Y Bozo; A A Isaev
Journal:  Biomed Res Int       Date:  2015-11-15       Impact factor: 3.411

6.  Non-erythropoietic erythropoietin-derived peptide protects mice from systemic lupus erythematosus.

Authors:  Bo Huang; Juntao Jiang; Bangwei Luo; Wen Zhu; Yuqi Liu; Zhishang Wang; Zhiren Zhang
Journal:  J Cell Mol Med       Date:  2018-03-23       Impact factor: 5.310

7.  MicroRNA expression profiling after recurrent febrile seizures in rat and emerging role of miR-148a-3p/SYNJ1 axis.

Authors:  Jian Xu; Mingqiang Sun; Xiaodong Li; Lei Huang; Zhenzhong Gao; Jian Gao; Anmu Xie
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

8.  Wuzi-Yanzong prescription alleviates spermatogenesis disorder induced by heat stress dependent on Akt, NF-κB signaling pathway.

Authors:  Su-Qin Hu; Dian-Long Liu; Chun-Rui Li; Ya-Hui Xu; Ke Hu; Li-Dan Cui; Jian Guo
Journal:  Sci Rep       Date:  2021-09-22       Impact factor: 4.379

9.  Nonerythropoietic Erythropoietin-Derived Peptide Suppresses Adipogenesis, Inflammation, Obesity and Insulin Resistance.

Authors:  Yuqi Liu; Bangwei Luo; Rongchen Shi; Jinsong Wang; Zongwei Liu; Wei Liu; Shufeng Wang; Zhiren Zhang
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379

10.  Altered Hemorheology in Fontan Patients in Normoxia and After Acute Hypoxic Exercise.

Authors:  Julian Alexander Härtel; Nicole Müller; Ulrike Herberg; Johannes Breuer; Daniel Alexander Bizjak; Wilhelm Bloch; Marijke Grau
Journal:  Front Physiol       Date:  2019-11-22       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.